IllumiNeuro Protocol (IllumiNeuro): Research, Mechanism & Current Evidence

What is IllumiNeuro Protocol?

IllumiNeuro is not a compound. It is a commercial blend containing four separate peptides studied in cognitive research: PE-22-28, Pinealon, NA-Semax Amidate and NA-Selank Amidate.

It exists as a vendor product rather than as a research subject, which is the single most important thing to understand about it.

What is IllumiNeuro Protocol researched for?

Each component has its own small research literature. PE-22-28 is studied as an antidepressant candidate in animal models; Pinealon in neuroprotection; the Semax and Selank variants in cognition and anxiety respectively.

There is no research programme on the combination.

• Combined BDNF support and neuritogenic effects may enhance memory formation and learning.
• NA-Semax component supports sustained attention and mental clarity.
• Multiple pathways protecting neural tissue from oxidative stress and damage.
• NA-Selank provides anxiolytic effects through GABA modulation.
• Immune-neuroendocrine support helps with stress resilience.
• Combined effects on neurotransmitter systems may improve overall mood.
• PE-22-28 promotes neural connectivity and neurite extension.
• Pinealon supports healthy sleep-wake cycles and pineal function.

How does IllumiNeuro Protocol work?

The four components act through unrelated mechanisms — potassium channel blockade, proposed gene-expression effects, and neurotrophic signalling. There is no published rationale explaining why combining them should be additive.

Combining compounds with different mechanisms is a hypothesis, not a finding.

What does the research show?

None specific to the blend. Any evidence cited for it belongs to individual components, and in several cases to the unmodified parent peptides rather than the modified versions actually included.

Limitations of the current evidence

Evidence for individual ingredients does not transfer to a mixture. Interactions between the four have not been studied.

Two of the four components are modified analogues whose own evidence base is thinner than that of their parent compounds.

References

1. PE-22-28 Neuritogenic Effects Neuroscience Research PE-22-28 promotes neurite outgrowth through S1P receptor modulation.

2. PE-22-28 promotes neurite outgrowth through S1P receptor modulation.

3. NA-Semax Amidate Cognitive Enhancement Multiple Studies Enhanced stability amidate form of Semax with BDNF upregulation and neuroprotective effects.

4. Enhanced stability amidate form of Semax with BDNF upregulation and neuroprotective effects.

5. NA-Selank Amidate Anxiolytic Properties Pharmacological Research Selank demonstrates anxiolytic effects through GABA modulation and immune-neuroendocrine regulation.

6. Selank demonstrates anxiolytic effects through GABA modulation and immune-neuroendocrine regulation.

7. Pinealon Bioregulator Russian Medical Literature Pinealon (EDR tripeptide) supports pineal gland function and circadian regulation.

8. Pinealon (EDR tripeptide) supports pineal gland function and circadian regulation.

Some statements on this page come from secondary summaries that we have not been able to trace to a primary source. Those are flagged here rather than presented as though they were fully referenced.

Common questions